Arrowgrass Capital Partners (US)’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-136,951	Closed	-$4.53M	–	194
2019 Q2	$4.53M	Buy	+136,951	New	+$4.53M	0.11%	130
2018 Q2	–	Sell	-98,600	Closed	-$4.52M	–	183
2018 Q1	$4.52M	Buy	+98,600	New	+$4.52M	0.15%	71